Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Munch-a-Biotech Today -- Ignore unavailable to you. Want to Upgrade?

To: Biomaven who wrote (215)	2/26/1999 2:44:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 3158

"I never make the same mistake twice - I just make one of its thousands of close relatives instead" Yeah, but I've exhausted those, too. When, oh, when will third-tier perform? Sigh. Nice discussion on NXTR, MZ, Peter. I completely missed it. I owned the old Vestar, before they merged with Nexagen. Interesting to see the evolution of the business plan, and how old is new. Harummmmmmph.

To: Biomaven who wrote (215)	2/28/1999 8:32:00 PM
From: LLCF	Respond to of 3158

<"I never make the same mistake twice - I just make one of its thousands of close relatives instead" - Victor Niederhoffer > <"Well, I'm right, but the market just won't admit it." - (myself)> Well, based on perfomance I'll take you Pete... I'm sure you read about Victors much publicized "meltdown" last fall! Good new for all of us calling "Mr.Market" an idiot. By the way Richare: < MLNM will be selling, IMO, for $200/share[...] INCY and AFFX are not competitors. Not to be a "nudge" but could you briefly explain why they arent competitors?? Thanks DAK